Riociguatum Long-acting formulation (Innopharmax )

利奥西呱长效制剂 (Innopharmax )

Report date: 2025/01/22 10:49:19

Base Information

Drug NameRiociguatum Long-acting formulation (Innopharmax )
Drug Alias NameD0292301D-0292301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble guanylate cyclase stimulants
TargetsSoluble guanylate cyclase
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInnopharmax Inc
China Registration ClassN/A

Develop Information

Active CompaniesInnopharmax Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A